Kukunda Lymphoma neDual CAR-T Therapy
Mukadzi ane makore makumi matanhatu nerimwe ekuberekwa, uyo akanga atsungirira kurapwa kwakawanda kwechirwere cheganda chakapararira B-Cell Lymphoma, kusanganisira chemotherapy inomwe, CAR-T therapy, uye PD-1 combined chemotherapy neradiation kakawanda, akazviwana ari panjodzi. Pasinei nekuedza kwake, mamiriro ake ezvinhu haana kuratidza kuvandudzika kusvika asvika kuBIOOCUS kuti awane rubatsiro rwakakosha.
Pakutanga kwa2021, chirwere chake chelymphoma chichikura nekukurumidza uye chichikonzera maronda eganda akakomba uye kuzvimba, mamiriro emurwere airatidzika kunge akaipa. Achitarisirwa nechikwata chakazvipira kuBIOOCUS, akatanga rwendo rutsva rwekurapwa. Mushure mekurapwa kwekutanga, mamiriro ake ezvinhu akadzikama, zvichikonzera kuunganidzwa nekukura kwemalymphocytes ake ekurapa CD19/CD22 CAR-T cell.
Musi wa19 Kukadzi 2021, akapihwa mushonga weCAR-T cell kaviri. Kunyangwe akasangana nemigumisiro inogoneka, PET-CT scans yakatevera yakaratidza kuvandudzika kukuru. Pakazosvika Kurume, akawana kurerukirwa kwakanyanya, zvichiratidza shanduko huru mukurwisa kwake kenza.
Iye zvino, makore matatu mushure mekurapwa kweCAR-T, ari kushingaira kugovera nyaya yake yekupora paFourth Lymphoma yeChina Musangano weVarwere, achikurudzira vamwe vari kutarisana nematambudziko akafanana. Rwendo rwake rwunosimbisa kufambira mberi mukurapa kweCAR-T uye basa rakakosha remushonga wemunhu mukurapa lymphomas dzakaoma.
Nekuda kwerubatsiro rwakakwana rwekuBIOOCUS, anoramba achibudirira, achisimbisa kukosha kwekurapa kutsva uye rutsigiro rwevashandi vehutano vakazvipira mukukunda kenza.